-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hc9n0/xL6gVDlNFWmAdfX5/zCcBr4oERmv6gbEXPQYXnPC44CKrwbpNi4SMpjmwN tFnpJw82/LFlptxD7Mfrzw== 0000950123-10-037131.txt : 20100719 0000950123-10-037131.hdr.sgml : 20100719 20100422150211 ACCESSION NUMBER: 0000950123-10-037131 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 CORRESP 1 filename1.htm corresp
April 22, 2010
Via Facsimile and EDGAR
Jeffrey P. Riedler
Assistant Director
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re:   Watson Pharmaceuticals, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2009
Filed March 1, 2010
File No. 1-13305
DEF14A
Filed March 29, 2010
File No. 001-13305
Dear Mr. Riedler:
     This letter is to confirm the substance of the telephone discussion on April 22, 2010 between Darrell Baker, Director of Financial Reporting and Ms Nandini Acharya of your office. Pursuant to that exchange, we advised your office, and your office acknowledged, that Watson intends to provide a substantive response to your letter dated April 9, 2010 within ten business days from today’s date.
     If you have any questions concerning the foregoing, please call me at (973) 355-8300.
         
Sincerely,


Watson Pharmaceuticals, Inc.
 		    
/s/ R. Todd Joyce      
R. Todd Joyce     
Senior Vice President and Chief Financial Officer     
 
cc:   Woodrow Anderson (PricewaterhouseCoopers LLP)

-----END PRIVACY-ENHANCED MESSAGE-----